Business · Companies · 1 hr ago
EssilorLuxottica heir reveals drug struggles as rift with CEO grows
An heir to EssilorLuxottica has revealed struggles with drugs.
The heir’s name is not given in the available details.
The details also do not identify the CEO.
They say the heir’s relationship with the CEO has become more strained.
No further background on the dispute or its effect on the company is provided.
No next steps are described.
An heir to EssilorLuxottica has revealed struggles with drugs.
The disclosure comes as the heir’s rift with the company’s CEO grows.
The source does not name the heir or CEO or give further details.
- Who
- An EssilorLuxottica heir and the company’s CEO; neither is named.
- What
- The heir revealed drug struggles as a rift with the CEO grew.
- When
- Not stated.
- Where
- Not stated.
- Why
- Not stated.
This story does not have two clearly opposing sides.
No direct quotes in the coverage so far.
This story does not have a timeline yet.
- Company
- EssilorLuxottica
- Disclosure
- An heir revealed drug struggles
- Relationship
- The heir’s rift with the CEO is growing
Sources
Related news
Italy forecasts 15.4 million cruise passengers in 2026, up 4.3%
MPS calls emergency board meeting after Intesa bid changes
European markets rise as investors watch earnings and energy prices
Tata Motors raises Iveco offer to €14.40 per share
Thieves steal 30,000 bottles worth €5 million from Antinori winery
Milan shares rise 0.75% as Avio and Stellantis lead gains
Stellantis chair John Elkann visits BYD stand at Paris auto show
Alfa Romeo looks beyond Italy for international growth
Lavazza plans to expand its Nuvola complex in Turin
Orsini says Italy’s investment tax relief should continue
Italian firms could not find 1.6 million workers with green skills
